2022 Rosenman Innovators
Meet the talented healthtech founders joining our wonderful community.
![](https://rosenmaninstitute.org/wp-content/uploads/2022/06/Innovators_Aila-1024x512.jpg)
Aila Health is a virtual care company supporting the 50M Americans living with autoimmune disease with integrative, multispecialty care and remote monitoring tools.
![](https://rosenmaninstitute.org/wp-content/uploads/2022/06/Innovators_ATDev-1-1024x512.png)
ATDev is building the future of assistive technology. Their product, Rehab Robo, redefines the standard of care for post surgical physical therapy by combining exoskeleton technology with the telehealth experience.
![](https://rosenmaninstitute.org/wp-content/uploads/2022/06/Innovators_Corveus-2-1024x512.png)
Corveus is creating a catheter that ablates the splanchnic nerve to prevent heart failure. Their device can uniquely access this nerve that was previously only accessible during surgery.
![](https://rosenmaninstitute.org/wp-content/uploads/2022/06/Innovators_Efemoral-1-1024x512.png)
Efemoral Medical is a clinical stage start-up developing a novel bioresorbable drug-eluting scaffold specifically designed to treat peripheral arterial disease, a condition that afflicts over 200 million people worldwide.
![](https://rosenmaninstitute.org/wp-content/uploads/2022/06/Innovators_Intellihealth-1-1024x512.png)
Intellihealth’s Evolve platform is a turnkey solution that easily integrates into the existing health care ecosystem to streamline all aspects of medical obesity care, including assessment, diagnosis, prescription and treatment.
![](https://rosenmaninstitute.org/wp-content/uploads/2022/06/Innovators_knowRX-2-1024x512.png)
A cloud-based digital healthcare platform with optimized clinical trial recruitment and retention of underrepresented participants along with new site locations services.
![](https://rosenmaninstitute.org/wp-content/uploads/2022/06/Innovators_LumiHealth-2-1024x512.png)
The Lumi Health AI-driven Intelligent Care Platform focuses physicians on the most urgent and important medication improvement opportunities for Heart Failure patients. Lumi Health does this 100x faster than it’s done today.
![](https://rosenmaninstitute.org/wp-content/uploads/2022/06/Innovators_NeuraStasis-1-1024x512.png)
NeuraStasis is developing the AED for stroke – a noninvasive neurostimulation device that presses pause on stroke progression to give providers more time to intervene.
![](https://rosenmaninstitute.org/wp-content/uploads/2022/06/Innovators_Neurovalens-2-1024x512.png)
Neurovalens makes non-invasive technology that treats type 2 diabetes by stimulating the area of the brainstem that regulates glucose. Phase III trials are scheduled to finish in late 2022.
![](https://rosenmaninstitute.org/wp-content/uploads/2022/06/Innovators_Rhaeos-1-1024x512.png)
FlowSense, is a wireless and noninvasive flow sensor that can be mounted on skin overlying the shunt to detect the magnitude of fluid flow through shunts in patients with hydrocephalus.
![](https://rosenmaninstitute.org/wp-content/uploads/2022/06/Innovators_SanaHealth-2-1024x512.png)
FDA Breakthrough device designation for fibromyalgia (class II), Sana is an audiovisual neuromodulation device that gives anxiety relief on demand, giving it applications across pain, mental health, and long covid.